Low Prevalence of Hepatitis C Virus Antibodies and RNA in Patients with Myocarditis and Dilated Cardiomyopathy

Abstract

We investigated the prevalence of hepatitis C virus in patients with dilated cardiomyopathy (DCM) and myocarditis in comparison to a control group of patients suffering from noninflammatory cardiac diseases such as aortic stenosis. In contrast to the results of previous studies on small numbers of patients, no significant difference in the prevalence of hepatitis C infections was observed. Our data suggest that HCV is not an important causal agent for myocarditis and DCM.

Journal

Journal ID (publisher-id): CRD

Journal ID (nlm-ta): Cardiology

Journal ID (doi): 10.1159/issn.0008-6312

Title: Cardiology

Publisher: S. Karger AG

ISSN (Print): 0008-6312

ISSN (Electronic): 1421-9751

Publication date Subscription-year: 1998

Publication date (Print): October 1998

Publication date (Electronic): 28 October 1998

Volume: 90

Issue: 2

Pages: 75-78

Affiliations

^a Department of Cardiology, Division of Internal Medicine, and ^b Department of Medical Microbiology, Georg-August-Universität, Göttingen, ^c Department of Cardiology, Friedrich-Schiller-Universität, Jena, Germany

Article

Publisher ID: 6822 Other ID: Cardiology 1998;90:75–78

DOI: 10.1159/000006822

PubMed ID: 9778541

Copyright statement: © 1998 S. Karger AG, Basel

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Page count

Tables: 2, References: 18, Pages: 4

Product

Self URI (application/pdf): https://www.karger.com/Article/Pdf/6822

Self URI (text/html): https://www.karger.com/Article/FullText/6822

Self URI (journal page): https://www.karger.com/SubjectArea/Cardiovascular-System

Categories

Subject: General Cardiology